Skip to content
Business

Boston's Latitude Beverage Bets On $69.99 Bourbon In First Year-Round Launch

Copper & Cask, a brand of Boston-founded Latitude Beverage, says its 10-year barrel-proof bourbon "X" will be sold nationally in ongoing small batches.

Boston's Latitude Beverage Bets On $69.99 Bourbon In First Year-Round Launch
Courtesy of Copper & Cask

Copper & Cask, the whiskey brand owned by Boston-based Latitude Beverage Company, said on October 6 that it is introducing a 10-year age-stated bourbon called "X," its first product intended to stay on shelves year-round rather than sell as a one-off.

According to the company's announcement distributed by PR Newswire, the bourbon will be released in recurring small batches and reach select retailers nationwide and the brand's website during October 2026. The suggested retail price is $69.99 for a barrel-proof bottle.

The first batch draws on 45 hand-picked barrels aged 10 to 12 years, mixing lower- and higher-rye bourbon distilled at MGP Indiana. The company said the barrels matured in Kentucky, Indiana and at its own Rhode Island headquarters.

The blend was overseen by Barrel Master Stephen Corrigan, who has run the barrel program since 2022. Corrigan said the company "wanted our first ongoing release to make a statement" and searched its inventory for older, distinctive barrels.

Latitude Beverage, founded in Boston in 2009 and independently owned, launched Copper & Cask in 2021 as an independent bottler focused on single-barrel picks and cask-strength small batches. Its other brands include Wheel Horse Whiskey, 90+ Cellars and Tequila Zarpado.

This story was first reported by PR Newswire.

More from Boston Business Watch

Most read this week

  1. 1How a Maine Marketing Agency Built the Software That Runs Its Clients' Businesses
  2. 2Blackstone Ice Cream Shop Goes Viral After Backing Teen Worker
  3. 3Marlborough Cleaning Firm Pushes Into Hartford, Providence Markets
  4. 4Seacoast Home Listings Hit Multiyear High As Sales Cool
  5. 5BD Marks 65 Years In Canaan, Pours $34M Into Syringe Plant

Comments

Comments are reviewed before they appear. Read our comment policy.